Cargando…

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China

BACKGROUND: Human papillomavirus (HPV) attributable cancer burden is currently unknown in China, which is essential to evaluate the potential benefit of existing HPV https://www.sciencedirect.com/topics/medicine-and-dentistry/vaccine and to inform cancer control policy. METHODS: We extracted data of...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Rufei, Qiao, Youlin, Clifford, Gary, Zhao, Fanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943148/
https://www.ncbi.nlm.nih.gov/pubmed/31714036
http://dx.doi.org/10.1002/cam4.2697
_version_ 1783484831258116096
author Duan, Rufei
Qiao, Youlin
Clifford, Gary
Zhao, Fanghui
author_facet Duan, Rufei
Qiao, Youlin
Clifford, Gary
Zhao, Fanghui
author_sort Duan, Rufei
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) attributable cancer burden is currently unknown in China, which is essential to evaluate the potential benefit of existing HPV https://www.sciencedirect.com/topics/medicine-and-dentistry/vaccine and to inform cancer control policy. METHODS: We extracted data of cancer incidence and mortality in 2014 from Chinese Cancer Registry Annual Report, and data of national population from National Bureau of Statistics. HPV‐attributable cancer burden was estimated by incorporating cancer rates and population forecasts by sex, cancer site, age and geographical area, and then combined to corresponding population attributable fractions. RESULTS: We estimated that there were 110 894 HPV‐attributable new cancer cases in China in 2014, including 99 253 cervical cancers, 4449 noncervical cancers in females and 7192 cancers in males. The age‐standardized incidence of HPV‐attributable cancers in China was 5.69 per 100 000 persons, being slightly higher in rural than urban areas. Specifically, 51.1% of HPV‐attributable cervical cancers were diagnosed in women aged 40‐54 years, while 75.8% of noncervical cancers were diagnosed at 45‐79 years of age. Among males, 53.4% of cancers were diagnosed at 55‐74 years of age. Thirty five thousand six hundred and eighty three HPV‐attributable cancer deaths were estimated, including 29 683 due to cervical cancer, and 2307 and 3693 due to noncervical cancer in females and males, respectively. CONCLUSIONS: The cancer burden attributable to HPV in China is substantial. HPV vaccination and cervical screening should be prioritized.
format Online
Article
Text
id pubmed-6943148
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69431482020-01-07 Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China Duan, Rufei Qiao, Youlin Clifford, Gary Zhao, Fanghui Cancer Med Cancer Prevention BACKGROUND: Human papillomavirus (HPV) attributable cancer burden is currently unknown in China, which is essential to evaluate the potential benefit of existing HPV https://www.sciencedirect.com/topics/medicine-and-dentistry/vaccine and to inform cancer control policy. METHODS: We extracted data of cancer incidence and mortality in 2014 from Chinese Cancer Registry Annual Report, and data of national population from National Bureau of Statistics. HPV‐attributable cancer burden was estimated by incorporating cancer rates and population forecasts by sex, cancer site, age and geographical area, and then combined to corresponding population attributable fractions. RESULTS: We estimated that there were 110 894 HPV‐attributable new cancer cases in China in 2014, including 99 253 cervical cancers, 4449 noncervical cancers in females and 7192 cancers in males. The age‐standardized incidence of HPV‐attributable cancers in China was 5.69 per 100 000 persons, being slightly higher in rural than urban areas. Specifically, 51.1% of HPV‐attributable cervical cancers were diagnosed in women aged 40‐54 years, while 75.8% of noncervical cancers were diagnosed at 45‐79 years of age. Among males, 53.4% of cancers were diagnosed at 55‐74 years of age. Thirty five thousand six hundred and eighty three HPV‐attributable cancer deaths were estimated, including 29 683 due to cervical cancer, and 2307 and 3693 due to noncervical cancer in females and males, respectively. CONCLUSIONS: The cancer burden attributable to HPV in China is substantial. HPV vaccination and cervical screening should be prioritized. John Wiley and Sons Inc. 2019-11-12 /pmc/articles/PMC6943148/ /pubmed/31714036 http://dx.doi.org/10.1002/cam4.2697 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Duan, Rufei
Qiao, Youlin
Clifford, Gary
Zhao, Fanghui
Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
title Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
title_full Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
title_fullStr Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
title_full_unstemmed Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
title_short Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
title_sort cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in china
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943148/
https://www.ncbi.nlm.nih.gov/pubmed/31714036
http://dx.doi.org/10.1002/cam4.2697
work_keys_str_mv AT duanrufei cancerburdenattributabletohumanpapillomavirusinfectionbysexcancersiteageandgeographicalareainchina
AT qiaoyoulin cancerburdenattributabletohumanpapillomavirusinfectionbysexcancersiteageandgeographicalareainchina
AT cliffordgary cancerburdenattributabletohumanpapillomavirusinfectionbysexcancersiteageandgeographicalareainchina
AT zhaofanghui cancerburdenattributabletohumanpapillomavirusinfectionbysexcancersiteageandgeographicalareainchina